about
The pathophysiology of thrombocytopenia in chronic liver diseaseRisk of Immune Thrombocytopenic Purpura and Autoimmune Hemolytic Anemia Among 120 908 US Veterans With Hepatitis C Virus InfectionSustained response to combination therapy in a patient with chronic hepatitis C and thrombocytopenia secondary to alpha-interferon.Autoimmune thrombocytopenic purpura after autologous stem cell transplantation.Mycophenolate mofetil in the treatment of autoimmune HCV-associated haematological disorders showing steroid resistance or dependence.Autoimmune thrombocytopenia in chronic myeloid leukemia treated with interferon-alpha: differential diagnosis and possible pathogenesis.Immune thrombocytopenic purpura in a patient treated with interferon alfacon-1.Autoimmune thrombocytopenia induced by PEG-IFN-alpha plus ribavirin in hepatitis C.Platelet autoantibodies are common in hepatitis C infection, irrespective of the presence of thrombocytopenia.Life-threatening thrombocytopenia and nephrotic syndrome due to focal segmental glomerulosclerosis associated with pegylated interferon alpha-2b and ribavirin treatment for hepatitis C.Interferon-alpha induced severe thrombocytopenia: a case report and review of the literature.Factors linked to severe thrombocytopenia during antiviral therapy in patients with chronic hepatitis c and pretreatment low platelet countsSevere immune thrombocytopenia after peg-interferon-alpha2a, ribavirin and telaprevir treatment completion: A case report and systematic review of literatureLate-Onset Immune Thrombocytopenic Purpura After Withdrawal of Interferon Treatment for Chronic Hepatitis C Infection: A Case ReportCurrent evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy.Management of Hepatitis C Antiviral Therapy Adverse Effects.Understudied populations with hepatitis C.Unexpected hematologic effects of biotherapeutics in nonclinical species and in humans.Recombinant interferon alpha 2b in rheumatoid arthritis: good antigen for rheumatoid arthritis antibodies.
P2860
Q26749277-50832ED7-D3AF-42EC-9B41-57B91E6DB471Q27490427-7D0AF42C-CF64-42A4-8006-D11BE5C4CDE3Q33332747-FD5411B1-B484-4E48-8349-E066B38DFD94Q33348608-40E2F29F-168E-408A-B499-659FFC800FD1Q33349902-AED8DBBC-3E8C-4A30-906C-9B8E78307D9BQ33359521-317F5AC8-29B2-4FAE-85D6-FC92C3FAA11DQ33362537-DC416275-F66C-4D9D-AE29-3C9E519351C4Q33372361-DF856DC8-8BA0-4F78-95DB-FB9BFC445F9BQ33372989-163C95AE-510D-4D8F-8901-17DA8C9B1142Q33373277-1D06327A-8900-4F93-9818-2C7203BA8BECQ33388664-641514AF-C1CA-449A-B127-8243A7D7AFC8Q33399240-E5E992F9-045E-4341-BDE6-EA0D7592651CQ33424123-8774590C-3296-4B2F-9D71-D414AB498DB3Q33425472-90D868F8-81ED-4931-899A-46F297C0276BQ33973488-E9140240-3213-45A5-B206-069E969462BDQ34538771-06355B3C-42A3-4FE0-86C5-E138ACE48389Q34984136-25E89D15-D0D4-4A51-A75F-6589CD720AF3Q38087506-CD3BE431-CF4F-42D4-9C18-4FDDA63C9908Q55405636-F9E214B8-861A-4F4C-A883-3410FD501A12
P2860
description
1996 nî lūn-bûn
@nan
1996 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Immune thrombocytopenia and alpha-interferon therapy.
@ast
Immune thrombocytopenia and alpha-interferon therapy.
@en
type
label
Immune thrombocytopenia and alpha-interferon therapy.
@ast
Immune thrombocytopenia and alpha-interferon therapy.
@en
prefLabel
Immune thrombocytopenia and alpha-interferon therapy.
@ast
Immune thrombocytopenia and alpha-interferon therapy.
@en
P2093
P1476
Immune thrombocytopenia and alpha-interferon therapy.
@en
P2093
Dourakis SP
Hadziyannis SJ
P304
P356
10.1016/S0168-8278(96)80304-7
P577
1996-12-01T00:00:00Z